Loading company…
Thrixen provides diagnostic technology for multiplex testing and biomarker identification.
Thrixen develops diagnostic technology for point-of-care multiplex tests across panels including inflammation, endocrine, allergens, viruses, tropical diseases, respiratory conditions and cardiac markers. Founded in 2021, the company is based in Singapore and was co-founded by Patthara Kongsuphol, Huan Jia, Peter Preiser, Megan McBee and Hadley Sikes. In April 2024, it raised USD 7 million co-led by 22Health Ventures and an individual investor.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in